A tonsil organoid model reveals Epstein-Barr virus-infected germinal center B cell states during primary infection.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42594281.
- Also identified by DOI 10.1073/pnas.2603586123.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Epstein-Barr virus (EBV) colonizes secondary lymphoid tissues to establish persistent infection and is strongly associated with malignancy and autoimmunity. Our understanding of EBV infection biology is hindered by a lack of models that capture infected B cell activity in the lymphoid tissue microenvironment. We therefore developed an EBV human tonsil organoid model to evaluate key B cell states and antiviral responses, including after primary infection. EBV promoted B cell differentiation into germinal center-like phenotypes and transcriptomic analyses highlighted numerous B cell transcriptional programs unique to EBV-infected cells. B cell receptor repertoire analysis revealed that most EBV<sup>+</sup> B cells underwent class switching but only rarely participated in somatic hypermutation. CD4 T cells, highly activated by organoid infection, limited EBV<sup>+</sup> B cell outgrowth in both primary and secondary EBV infection. Our findings demonstrate human tonsil organoids as a physiologically relevant model to investigate key aspects of EBV immunity and pathogenesis.
Medical subject headings
- Germinal Center
- B-Lymphocytes
- Organoids
- Palatine Tonsil
- Herpesvirus 4, Human
- Epstein-Barr Virus Infections